Bain Capital has become the latest private markets investor to back a pan-Asian data center platform with the merger of existing portfolio companies covering China, Southeast Asia, and India.
Earlier this year, the GP acquired a majority stake in the data center division of Shenzhen-listed NetScience Technology for RMB990 million ($147 million). This asset – known as ChinaData – has now...
Increased climate change awareness on a corporate level is leading to more investment – either direct or through funds – in start-ups that offer mitigation solutions. Asia is a key geography
Healthcare-focused Panacea Venture has led a $40 million Series C round for China’s XWPharma, a neurobiology-focused biotech developer previously known as XW Laboratories.
Kyee Technology, a Chinese digital medical platform has raised RMB430 million ($64 million) in a Series D round led by Tencent Holdings. Other investors include Longmen Capital, Dyee Capital and Royal Sea Capital.
Biocytogen, a Chinese contract research organization (CRO) that provides genetically-modified mice for drug testing, has raised RMB970 million ($143 million) in an extended tranche of Series D funding.